Discover
DWTX
Dogwood Therapeutics, Inc.
1.50
2 x 1.13
2 x 1.89
bid
ask
-
0.11
6.83%
2 @ 06:20 AM
1.62 +0.12 (8.00%)
| Ytd | -63.94% | |
| 1y | -69.70% |
1.49
day range
1.64
1.28
52 week range
9.50
| Open | 1.64 | Prev Close | 1.61 | Low | 1.49 | High | 1.64 | Mkt Cap | 50.44M |
| Vol | 135.85K | Avg Vol | 103.02K | EPS | 1.17 | P/E | 1.28 | Forward P/E | -0.43 |
| Beta | 1.57 | Short Ratio | 0.42 | Inst. Own | 3.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.60 | 200-d Avg | 3.63 | 1yr Est | 13.83 |
| Income Statement | |||
| Operating Expenses | 5.08M | ||
| Research and Development Expense | 2.67M | ||
| Selling, General and Administrative Expense | 2.41M | ||
| Operating Income | -5.08M | ||
| Interest Expense | -77.35K | ||
| Income Tax Expense | 1.19K | ||
| Net Income | -4.99M | ||
| Net Income Common Stock | -4.99M | ||
| Net Income Common Stock (USD) | -4.99M | ||
| Consolidated Income | -4.99M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -5.06M | ||
| Earning Before Interest & Taxes (USD) | -5.06M | ||
| Weighted Average Shares | 33.54M | ||
| Weighted Average Shares Diluted | 33.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.23M | ||
| Cash and Equivalents (USD) | 13.23M | ||
| Current Assets | 15.00M | ||
| Property, Plant & Equipment Net | 159.29K | ||
| Total Assets | 95.21M | ||
| Total Debt | 87.62K | ||
| Current Liabilities | 2.56M | ||
| Debt Non-Current | 87.62K | ||
| Total Liabilities | 14.58M | ||
| Accumulated Retained Earnings (Deficit) | -113.06M | ||
| Accumulated Other Comprehensive Income | -1.72M | ||
| Shareholders Equity | 80.62M | ||
| Shareholders Equity (USD) | 80.62M | ||
| Assets Non-Current | 80.20M | ||
| Total Debt (USD) | 87.62K | ||
| Deferred Revenue | 38.29K | ||
| Goodwill and Intangible Assets | 80.03M | ||
| Liabilities Non-Current | 12.02M | ||
| Trade and Non-Trade Payables | 144.40K | ||
| Tax Liabilities | 11.91M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 16.84K | ||
| Net Cash Flow from Financing | 11.29M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.70M | ||
| Issuance (Purchase) of Equity Shares | 11.40M | ||
| Net Cash Flow from Operations | -4.59M | ||
| Effect of Exchange Rate Changes on Cash | -1.04K | ||
| Share Based Compensation | 449.42K | ||